Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction-Reference-Cited by-同舟云学术

Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction

Published:2021-12 Issue:12 Volume:9 Page:876-886
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Carnicelli Anthony P.,Li Zhen,Greiner Melissa A.,Lippmann Steven J.,Greene Stephen J.,Mentz Robert J.,Hardy N. Chantelle,Blumer Vanessa,Shen Xian,Yancy Clyde W.,Peterson Pamela N.,Allen Larry A.,Fonarow Gregg C.,O’Brien Emily C.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014

2. Clinical outcomes in patients with acute decompensated heart failure randomly assigned to sacubitril/valsartan or enalapril in the PIONEER-HF trial;Morrow;Circulation,2019

3. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry;Greene;J Am Coll Cardiol,2018

4. Sacubitril/Valsartan Initiation and Post-discharge Adherence Among Patients Hospitalized for Heart Failure;Carnicelli;J Am Coll Cardiol HF,2019

5. Practical guidance on the use of sacubitril/valsartan for heart failure;Sauer;Heart Fail Rev,2019

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum;European Heart Journal - Digital Health;2024-08-30

2. Medication adherence and persistence in heart failure: A protocol for a systematic review and meta-analysis;Farmacia Hospitalaria;2024-08

3. Effect of sacubitril/valsartan on hospital readmissions in heart failure with reduced ejection fraction in Saudi Arabia: A multicenter retrospective cohort study;Medicine;2024-07-26

4. The contemporary role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and angiotensin receptor-neprilysin inhibitor (ARNI) in the management of heart failure: State-of-the-art review;Indian Heart Journal;2024-07

5. Cardiac contractility modulation in patients with heart failure: The added value of cardiac rehabilitation in identification, management, and follow-up;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-06